EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring genotype–phenotype correlations in glutaric aciduria type 1

Imke M E Schuurmans iD, Bianca Dimitrov iD, Julian Schröter iD, Antonia Ribes iD, Rubén Pérez de la Fuente iD, Berta Zamora iD, Clara D M van Karnebeek iD, Stefan Kölker, Alejandro Garanto iD

Journal of Inherited Metabolic Disease · 2023

DOI: 10.1002/jimd.12608 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2023. Verfasst von Imke M E Schuurmans und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Brain Diseases, Metabolic, Amino Acid Metabolism, Inborn Errors. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Departament de Salut, Generalitat de Catalunya, Mutua Madrileña Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutaric aciduria type 1 (GA1) is a rare neurometabolic disease caused by pathogenic variants in the gene encoding the enzyme glutaryl‐CoA dehydrogenase (GCDH). We performed an extensive literature search to collect data on GA1 patients, together with unpublished cases, to provide an up‐to‐date genetic landscape of GCDH pathogenic variants and to investigate potential genotype‐phenotype correlation, as this is still poorly understood. From this search, 421 different GCDH pathogenic variants have been identified, including four novel variants; c.179T>C (p.Leu60Pro), c.214C>T (p.Arg72Cys), c.309G>C (p.Leu103Phe), and c.665T>C (p.Phe222Ser).The variants are mostly distributed across the entire gene; although variant frequency in GA1 patients is relatively high in the regions encoding for active domains of GCDH . To investigate potential genotype‐phenotype correlations, phenotypic descriptions of 532 patients have been combined and evaluated using novel combinatorial analyses. To do so, various clinical phenotypes were determined for each pathogenic variant by combining the information of all GA1 patients reported with this pathogenic variant, and subsequently mapped onto the 2D and 3D GCDH protein structure. In addition, the predicted pathogenicity of missense variants was analyzed using different in silico prediction score models. Both analyses showed an almost similar distribution of the highly pathogenic variants across the GCDH protein, although some hotspots, including the active domain, were observed. Moreover, it was demonstrated that highly pathogenic variants are significantly correlated with lower residual enzyme activity and the most accurate estimation was achieved by the REVEL score. A clear correlation of the genotype and the clinical phenotype however is still lacking.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain Diseases, MetabolicAmino Acid Metabolism, Inborn ErrorsMutation, MissenseHumansGlutaryl-CoA Dehydrogenase

Stichwörter der Autor:innen

GCDH variantsglutaric aciduria type 1lysine catabolism disorderpathogenicity scorephenotype-genotype correlation

Substanzen

Glutaryl-CoA Dehydrogenase

Autor:innen und Institutionen

  • Department of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Pediatrics and Human Genetics, Emma Center for Personalized Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Division of Child Neurology and Metabolic Medicine, Centre for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Division of Pediatric Epileptology, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

ORCID-Profile: Imke M E Schuurmans, Bianca Dimitrov, Julian Schröter, Antonia Ribes, Rubén Pérez de la Fuente, Berta Zamora, Clara D M van Karnebeek, Alejandro Garanto

Förderung

  • Departament de Salut, Generalitat de Catalunya
  • Mutua Madrileña Foundation

Zitieren

APA

Schuurmans, I. M. E., Dimitrov, B., Schröter, J., Ribes, A., de la Fuente, R. P., Zamora, B., van Karnebeek, C. D. M., Kölker, S., & Garanto, A. (2023). Exploring genotype–phenotype correlations in glutaric aciduria type 1. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12608

Vancouver

Schuurmans IME, Dimitrov B, Schröter J, Ribes A, de la Fuente RP, Zamora B, et al. Exploring genotype–phenotype correlations in glutaric aciduria type 1. Journal of Inherited Metabolic Disease. 2023. doi:10.1002/jimd.12608

BibTeX
@article{Schuurmans2023,
  author = {Schuurmans, Imke M E and Dimitrov, Bianca and Schröter, Julian and Ribes, Antonia and de la Fuente, Rubén Pérez and Zamora, Berta and van Karnebeek, Clara D M and Kölker, Stefan and Garanto, Alejandro},
  title = {Exploring genotype–phenotype correlations in glutaric aciduria type 1},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2023},
  doi = {10.1002/jimd.12608}
}
Kostenlos starten →